HEALTHSTORY 749· JULY 4, 2026

Roche Drug Sets New Standard for KRAS-Driven Lung Cancer

A Roche drug has established a new treatment standard for KRAS-driven lung cancer, STAT+ reported, marking a significant moment in an oncology target that has long resisted effective therapy. The news lands as the broader biotech sector's…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 748FBI Director Kash Patel Filed Late Disclosure on Strategy Stock, Reports Say NEXT STORY 750 →North Island Credit Union Collects School Backpacks for San Diego Youth Through Boys & Girls Clubs Partnership

Keep reading

More from the desk.

05HEALTH

Doctors groups release vaccination guidelines ahead of respiratory illness season

Vaccination guidance for the coming winter respiratory season is now available for both medical professionals and their patients. The short version: a coalition of professional organizations representing pediatricians, family physicians…

health1 MIN

09HEALTH

Trump's pharma deals may not deliver on drug cost promises

Voluntary drug pricing agreements between the White House and midsize biotechnology companies are unlikely to change what most Americans pay for their prescriptions, at least in the near term, analysts say. The agreements follow a…

health1 MIN

13HEALTH

ADA internal review clears group of censorship after members ejected in New Orleans

An internal review, meaning an investigation the organization runs into its own conduct using a committee it appoints, has cleared the American Diabetes Association of censoring five members ejected from its scientific conference in New…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk